AUROPHARMA - BREAKOUT FOR BUY
Auropharma has been a good performer from the IPO stages. However it entered consolidation stage from 2015-2020. Now the stock is getting ready to move up into new range. Buy for longterm investors.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。